Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D, Julien M, Fagniez P L
Department of Digestive Surgery, Hôpital Henri Mondor-Université Paris XII, Créteil, France.
Arch Surg. 1995 Oct;130(10):1073-8. doi: 10.1001/archsurg.1995.01430100051011.
To report the results of a deliberately aggressive surgical management in patients with intrahepatic cholangiocarcinoma.
A case series of patients with intrahepatic cholangiocarcinoma.
A tertiary care university hospital in a metropolitan area.
From 1989 to 1993, 19 patients with intrahepatic cholangiocarcinoma underwent laparotomy, with a 74% resectability rate (14 liver resections). In addition, two selected patients with a slow-growing tumor underwent orthotopic liver transplantation after limited recurrence following resection in one case and after exploratory laparotomy in the other.
The 14 liver resections included six right or left hepatectomies and eight extended right or left hepatectomies. Total vascular exclusion of the liver was used in nine cases (64%) and resection of the biliary confluence with reconstruction was used in six cases (43%).
There was one postoperative death (7%). There were four postoperative biliary fistulas (28%). Overall actuarial 1- and 2-year survival rates were 58% and 32%, respectively. The 1- and 2-year survival rates were 100% after curative resection (no lymph node invasion, clearance margin of < or = 1 cm, and solitary tumor [five cases]) and 48% and 10% after palliative resection. Median survival was 14 months for the whole series and 27 and 9 months following curative and palliative resections, respectively. The two liver transplant recipients are alive and free of disease at 25 and 31 months.
These results support aggressive surgical management in patients with intrahepatic cholangiocarcinoma, including complex liver resection procedures and selective use of orthotopic liver transplantation.
报告对肝内胆管癌患者采取积极手术治疗的结果。
肝内胆管癌患者病例系列。
大都市地区的一家三级护理大学医院。
1989年至1993年,19例肝内胆管癌患者接受了剖腹手术,切除率为74%(14例肝切除术)。此外,两名肿瘤生长缓慢的患者在一例切除术后有限复发以及另一例剖腹探查术后接受了原位肝移植。
14例肝切除术包括6例右半肝或左半肝切除术以及8例扩大右半肝或左半肝切除术。9例(64%)采用了全肝血管阻断,6例(43%)采用了胆管汇合部切除并重建。
术后死亡1例(7%)。术后发生4例胆瘘(28%)。总体1年和2年精算生存率分别为58%和32%。根治性切除(无淋巴结侵犯、切缘<或=1 cm且为孤立肿瘤[5例])后1年和2年生存率为100%,姑息性切除后为48%和10%。整个系列的中位生存期为14个月,根治性和姑息性切除后分别为27个月和9个月。两名肝移植受者分别在25个月和31个月时存活且无疾病。
这些结果支持对肝内胆管癌患者采取积极手术治疗,包括复杂的肝切除手术和选择性原位肝移植的应用。